M a n u s c r i p t 
Introduction
Antimicrobial agents play a crucial role in the treatment of infectious diseases.
However, excessive and inappropriate use of antimicrobial agents has caused global increases in antimicrobial resistance (AMR) [1] [2] [3] . The emergence of resistant bacteria has resulted in treatment failures, increased mortality and significant healthcare costs [4, 5] . The prevalence of resistance across a range of bacteria is high in Asia and specifically in South Korea [6] . According to an economic evaluation of AMR associated with meticillin-resistant Staphylococcus aureus (MRSA),
implemented by the Korea Institute for Health and Social Affairs in 2006, the duration of hospital stay and the medical costs associated with AMR increased 1.8-fold and 1.25-fold, respectively [7] . The USA estimates the annual economic cost of AMR to be US$60 billion [8] . The World Health Organization (WHO) has repeatedly stated concerns about the increasing current and future threat posed by AMR and has strongly recommended strategic national and international approaches for AMR management [9, 10] .
In 2014, through the 67th World Health Assembly, the WHO emphasised the importance of the specific global action plans for AMR and presented a guideline of AMR control [11, 12] . The USA and UK have already established strategies for AMR as well as initiatives on nationwide management [13] [14] [15] .
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A c c e p t e d M a n u s c r i p t 6 AMR is increasing in South Korea. Since 2007, from the initiation of national surveillance programmes related to AMR, the prevalence of oxacillin-resistant S.
aureus is consistently around 60%. Imipenem-resistant Acinetobacter baumannii increased from 20% to 62%, and imipenem-resistant Pseudomonas aeruginosa also increased from 26% to 42% [16] . Furthermore, South Korea continuously receives significant numbers of medical tourists from neighbouring countries, including China, where emerging issues related to AMR continue to cause serious concerns [17, 18] .
There is also noted widespread AMR across other Asian countries [19] . South Korea is a member of the G20 countries and has the 13th largest economy in the world [20] . In 2013, Korean research and development expenditure was 4.1% of the country's overall gross domestic product (GDP), second only to Israel and significantly higher than other developed countries such as the USA, UK, Germany and China [21] . Thus, how South Korea invests its research budgets is of great importance, not just for public health in South Korea but potentially for the global health community as well. It is imperative that distribution of limited resources uses strategic and smart approaches. There have been previous studies investigating research investments for AMR in the UK and across Europe [24, 25] . This is the first study to describe the research investments related to AMR from the Korean funders (MFDS, MoHW and KCDC), which implemented NARSCP from 2003-2013 inclusive. We describe trends in total investment and across different types of research and also suggest future national and international research priorities. A c c e p t e d M a n u s c r i p t 8 directly related tuberculosis [26] . This study also excluded awards for research meeting support such as AMR-related academic symposiums. 1A ). The proportion of research awarded by categories from WHO showed that most projects were focused on basic microbial research and surveillance (Fig. 1B) . with total funding of $9 939 360 ($92 807 mean award). The distribution of the research pipeline was remained similar over the study period (Fig. 2) . Within the operational research category, there were 10 projects related to awareness improvement (of which 2 had a physician-related focus and 8 focused on awareness in the community), 33 for infection control, 11 for optimal use of antibiotics (of which 8 had a focus on physicians in hospitals and 3 focused on antibiotic use in the community) and 1 for economic evaluation.
Materials and methods

Data sources
Categorisation of awards
Result
By receiving research institution, academia (such as universities and academic societies) received 145 awards (73.2%) with total funding of $12 546 019 (68.3% of all investment) and public institutions such as national agencies received 44 awards Streptococcus. There was no clear association between the trend of annual investment and the resistance trends of major pathogens (Fig. 3 ). There were no included research projects that could be categorised as global health.
Discussion
The emphasis on AMR management has been increasing, as shown by the tourist interests and thus greatest potential for contributing to evolution of resistance trends). There is also an argument that it is an ethical imperative that South Korea, as a high-income country, should further contribute to global efforts to address AMR.
A limitation of this study is that it only considered the research projects conducted by the NARSCP-associated government agencies, which account for 12.1% of the total South Korea national fiscal budget and only considered the funding body's internal reporting systems [29] . Owing to resource constraints, we could not properly consider the impact or outputs of the research projects included here. The lack of private sector investment information is a main data gap of this study, and resource constraints meant we could not obtain and analyse data from the Korean Institute of Tuberculosis. We did not consider AMR related to virology, parasitology and tuberculosis. We also did not include research relating to development of new products that could impact on AMR trends, such as vaccines.
As the WHO has announced their AMR action plans, the importance of AMR management is receiving global attention. The WHO Global Observatory on Health R&D is also wishing to establish a global strategy to inform thinking about resource allocation for research, and this will require national and international data sets of R&D analyses across all areas of health [30] . Through the NARSCP portfolio, total investment in AMR research has steadily increased over time, as has the median Analyses such as these can support AMR surveillance systems and contribute to improved efforts regarding resource allocation for research-we must invest wisely.
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